Efficacy of High-flow Nasal Oxygen in Preventing Hypoxia During Gastrointestinal Endoscopy: a Retrospective Cohort Study
1 other identifier
observational
900
1 country
1
Brief Summary
During painless gastroscopy, the occurrence of hypoxia is a critical concern, especially under intravenous anesthesia using propofol. This study aimed to investigate the incidence of hypoxia during painless gastroscopy and evaluate preventive measures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 23, 2024
CompletedFirst Posted
Study publicly available on registry
November 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedDecember 16, 2024
December 1, 2024
7 months
November 23, 2024
December 11, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
incidence of hypoxia
SpO2 levels less than 90%
60 seconds
Secondary Outcomes (1)
the incidence of subclinical respiratory depression and adverse events
30 minute
Study Arms (2)
control group
conventional nasal cannula oxygen group
experimental group
high flow nasal cannula oxygen group
Eligibility Criteria
The patients who underwent painless gastroscopy
You may qualify if:
- Patients aged 18 to 70
- Undergoing painless gastroscopy under intravenous anesthesia
You may not qualify if:
- Severe respiratory disease
- History of nasal bleeding or mucosal injury
- Emergency cases
- Pregnant or lactating female
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fengli Liulead
Study Sites (1)
Nanchang University
Nanchang, Jiangxi, 330000, China
Biospecimen
Medical record
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fengli Liu, master
Nanchang University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Student
Study Record Dates
First Submitted
November 23, 2024
First Posted
November 29, 2024
Study Start
November 1, 2024
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
December 16, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share